Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Forecasting lung cancer incidence, mortality, and prevalence to year 2030

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Socioeconomic position and prediagnostic health care contacts in children with cancer in Denmark: a nationwide register study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cardiovascular disease in women with breast cancer - a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of [18F]FDG-PET and [18F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Daily Adaptive Proton Therapy: Is it Appropriate to Use Analytical Dose Calculations for Plan Adaption?

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Erik Jakobsen
  • Karen Ege Olsen
  • Mette Bliddal
  • Malene Hornbak
  • Gitte F. Persson
  • Anders Green
View graph of relations

Background: Lung cancer incidence and prevalence is increasing worldwide and there is a focus on prevention, early detection, and development of new treatments which will impact the epidemiological patterns of lung cancer. The clinical characteristics and the trends in incidence, mortality, and prevalence of lung cancer in Denmark from 2006 through 2015 are described and a model for predicting the future epidemiological profile of lung cancer through 2030 is introduced. Methods: The study population comprised all cases of lung cancer, registered in the Danish Cancer Registry, who were alive on January 1, 2006 or had a first-time ever diagnosis of lung cancer during 2006 through 2015. Information on morphology, stage of the disease, comorbidity and survival was obtained from other Danish health registers. Based on NORDCAN data and estimated patient mortality rates as well as prevalence proportions for the period 2006 through 2015, future case numbers of annual incidence, deaths, and resulting prevalence were projected. Results: A total of 44.291 patients were included in the study. A shift towards more patients diagnosed with lower stages and with adenocarcinoma was observed. The incidence increased and the patient mortality rate decreased significantly, with a doubling of the prevalence during the observation period. We project that the numbers of prevalent cases of lung cancer in Denmark most likely will increase from about 10,000 at the end of 2015 to about 23,000 at the end of 2030. Conclusions: Our findings support that lung cancer is being diagnosed at an earlier stage, that incidence will stop increasing, that mortality will decrease further, and that the prevalence will continue to increase substantially. Projections of cancer incidence, mortality, and prevalence are important for planning health services and should be updated at regular intervals.

Original languageEnglish
Article number985
JournalBMC Cancer
Volume21
Issue number1
ISSN1471-2407
DOIs
Publication statusPublished - Dec 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s).

    Research areas

  • Epidemiology, Incidence, Lung cancer, Mortality, Prevalence forecasting

ID: 69366794